Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2013-07-04 19:04:52 UTC |
---|
Update Date | 2021-09-14 15:00:01 UTC |
---|
HMDB ID | HMDB0060872 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Sorafenib beta-D-Glucuronide |
---|
Description | Sorafenib beta-D-Glucuronide belongs to the class of organic compounds known as n-glucuronides. These are glucuronides in which the aglycone is linked to the carbohydrate unit through a N-glycosidic bond. Sorafenib beta-D-Glucuronide is a moderately basic compound (based on its pKa). |
---|
Structure | CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)N([C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)C3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1 InChI=1S/C27H24ClF3N4O9/c1-32-23(39)18-11-15(8-9-33-18)43-14-5-2-12(3-6-14)34-26(42)35(13-4-7-17(28)16(10-13)27(29,30)31)24-21(38)19(36)20(37)22(44-24)25(40)41/h2-11,19-22,24,36-38H,1H3,(H,32,39)(H,34,42)(H,40,41)/t19-,20-,21+,22-,24+/m0/s1 |
---|
Synonyms | Value | Source |
---|
Sorafenib b-D-glucuronide | Generator | Sorafenib β-D-glucuronide | Generator |
|
---|
Chemical Formula | C27H24ClF3N4O9 |
---|
Average Molecular Weight | 640.949 |
---|
Monoisotopic Molecular Weight | 640.118390708 |
---|
IUPAC Name | (2S,3S,4S,5R,6R)-6-{1-[4-chloro-3-(trifluoromethyl)phenyl][(4-{[2-(methylcarbamoyl)pyridin-4-yl]oxy}phenyl)carbamoyl]amino}-3,4,5-trihydroxyoxane-2-carboxylic acid |
---|
Traditional Name | (2S,3S,4S,5R,6R)-6-{1-[4-chloro-3-(trifluoromethyl)phenyl][(4-{[2-(methylcarbamoyl)pyridin-4-yl]oxy}phenyl)carbamoyl]amino}-3,4,5-trihydroxyoxane-2-carboxylic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)N([C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)C3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1 |
---|
InChI Identifier | InChI=1S/C27H24ClF3N4O9/c1-32-23(39)18-11-15(8-9-33-18)43-14-5-2-12(3-6-14)34-26(42)35(13-4-7-17(28)16(10-13)27(29,30)31)24-21(38)19(36)20(37)22(44-24)25(40)41/h2-11,19-22,24,36-38H,1H3,(H,32,39)(H,34,42)(H,40,41)/t19-,20-,21+,22-,24+/m0/s1 |
---|
InChI Key | HALZWBPBJOJUOZ-QMDPOKHVSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as n-glucuronides. These are glucuronides in which the aglycone is linked to the carbohydrate unit through a N-glycosidic bond. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic oxygen compounds |
---|
Class | Organooxygen compounds |
---|
Sub Class | Carbohydrates and carbohydrate conjugates |
---|
Direct Parent | N-glucuronides |
---|
Alternative Parents | |
---|
Substituents | - 1-n-glucuronide
- N-glucuronide
- Hexose monosaccharide
- Diaryl ether
- Glycosyl compound
- N-glycosyl compound
- N-phenylurea
- Trifluoromethylbenzene
- Pyridine carboxylic acid or derivatives
- 2-heteroaryl carboxamide
- Phenoxy compound
- Phenol ether
- Beta-hydroxy acid
- Chlorobenzene
- Halobenzene
- Pyridine
- Pyran
- Hydroxy acid
- Aryl chloride
- Oxane
- Monosaccharide
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- Heteroaromatic compound
- Carboxamide group
- Urea
- Secondary carboxylic acid amide
- Secondary alcohol
- Carbonic acid derivative
- Carboxylic acid derivative
- Carboxylic acid
- Oxacycle
- Azacycle
- Ether
- Organoheterocyclic compound
- Polyol
- Monocarboxylic acid or derivatives
- Organochloride
- Organohalogen compound
- Organic nitrogen compound
- Alcohol
- Carbonyl group
- Organofluoride
- Organonitrogen compound
- Organopnictogen compound
- Alkyl fluoride
- Alkyl halide
- Organic oxide
- Hydrocarbon derivative
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Sorafenib beta-D-Glucuronide,1TMS,isomer #1 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O)C=C2)=CC=N1 | 4686.0 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,1TMS,isomer #2 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O)C=C2)=CC=N1 | 4660.4 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,1TMS,isomer #3 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O[Si](C)(C)C)C=C2)=CC=N1 | 4677.5 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,1TMS,isomer #4 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]3O)C=C2)=CC=N1 | 4665.5 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,1TMS,isomer #5 | CN(C(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)C=C2)=CC=N1)[Si](C)(C)C | 4728.7 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,1TMS,isomer #6 | CNC(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)[Si](C)(C)C)C=C2)=CC=N1 | 4471.3 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TMS,isomer #1 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O)C=C2)=CC=N1 | 4633.8 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TMS,isomer #10 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]3O[Si](C)(C)C)C=C2)=CC=N1 | 4616.1 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TMS,isomer #11 | CN(C(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O[Si](C)(C)C)C=C2)=CC=N1)[Si](C)(C)C | 4640.4 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TMS,isomer #12 | CNC(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O[Si](C)(C)C)[Si](C)(C)C)C=C2)=CC=N1 | 4417.7 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TMS,isomer #13 | CN(C(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]3O)C=C2)=CC=N1)[Si](C)(C)C | 4622.3 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TMS,isomer #14 | CNC(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]3O)[Si](C)(C)C)C=C2)=CC=N1 | 4406.0 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TMS,isomer #15 | CN(C(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)[Si](C)(C)C)C=C2)=CC=N1)[Si](C)(C)C | 4427.9 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TMS,isomer #2 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]3O)C=C2)=CC=N1 | 4633.0 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TMS,isomer #3 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O[Si](C)(C)C)C=C2)=CC=N1 | 4622.2 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TMS,isomer #4 | CN(C(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O)C=C2)=CC=N1)[Si](C)(C)C | 4652.4 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TMS,isomer #5 | CNC(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O)[Si](C)(C)C)C=C2)=CC=N1 | 4422.5 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TMS,isomer #6 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O)C=C2)=CC=N1 | 4607.7 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TMS,isomer #7 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O[Si](C)(C)C)C=C2)=CC=N1 | 4616.1 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TMS,isomer #8 | CN(C(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O)C=C2)=CC=N1)[Si](C)(C)C | 4627.1 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TMS,isomer #9 | CNC(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O)[Si](C)(C)C)C=C2)=CC=N1 | 4416.4 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,3TMS,isomer #1 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]3O)C=C2)=CC=N1 | 4587.1 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,3TMS,isomer #10 | CN(C(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O)[Si](C)(C)C)C=C2)=CC=N1)[Si](C)(C)C | 4389.9 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,3TMS,isomer #11 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O[Si](C)(C)C)C=C2)=CC=N1 | 4579.0 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,3TMS,isomer #12 | CN(C(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O)C=C2)=CC=N1)[Si](C)(C)C | 4568.5 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,3TMS,isomer #13 | CNC(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O)[Si](C)(C)C)C=C2)=CC=N1 | 4395.8 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,3TMS,isomer #14 | CN(C(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O[Si](C)(C)C)C=C2)=CC=N1)[Si](C)(C)C | 4586.7 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,3TMS,isomer #15 | CNC(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O[Si](C)(C)C)[Si](C)(C)C)C=C2)=CC=N1 | 4396.8 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,3TMS,isomer #16 | CN(C(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]3O)[Si](C)(C)C)C=C2)=CC=N1)[Si](C)(C)C | 4379.7 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,3TMS,isomer #17 | CN(C(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]3O[Si](C)(C)C)C=C2)=CC=N1)[Si](C)(C)C | 4573.5 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,3TMS,isomer #18 | CNC(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]3O[Si](C)(C)C)[Si](C)(C)C)C=C2)=CC=N1 | 4389.6 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,3TMS,isomer #19 | CN(C(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O[Si](C)(C)C)[Si](C)(C)C)C=C2)=CC=N1)[Si](C)(C)C | 4382.1 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,3TMS,isomer #2 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O[Si](C)(C)C)C=C2)=CC=N1 | 4582.1 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,3TMS,isomer #20 | CN(C(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]3O)[Si](C)(C)C)C=C2)=CC=N1)[Si](C)(C)C | 4368.4 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,3TMS,isomer #3 | CN(C(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O)C=C2)=CC=N1)[Si](C)(C)C | 4592.0 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,3TMS,isomer #4 | CNC(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O)[Si](C)(C)C)C=C2)=CC=N1 | 4401.1 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,3TMS,isomer #5 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]3O[Si](C)(C)C)C=C2)=CC=N1 | 4599.6 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,3TMS,isomer #6 | CN(C(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]3O)C=C2)=CC=N1)[Si](C)(C)C | 4604.5 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,3TMS,isomer #7 | CNC(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]3O)[Si](C)(C)C)C=C2)=CC=N1 | 4405.9 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,3TMS,isomer #8 | CN(C(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O[Si](C)(C)C)C=C2)=CC=N1)[Si](C)(C)C | 4603.9 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,3TMS,isomer #9 | CNC(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]3O[Si](C)(C)C)[Si](C)(C)C)C=C2)=CC=N1 | 4397.6 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,1TBDMS,isomer #1 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]3O)C=C2)=CC=N1 | 4849.4 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,1TBDMS,isomer #2 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]3O)C=C2)=CC=N1 | 4841.8 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,1TBDMS,isomer #3 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O[Si](C)(C)C(C)(C)C)C=C2)=CC=N1 | 4847.7 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,1TBDMS,isomer #4 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]3O)C=C2)=CC=N1 | 4859.5 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,1TBDMS,isomer #5 | CN(C(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)C=C2)=CC=N1)[Si](C)(C)C(C)(C)C | 4978.8 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,1TBDMS,isomer #6 | CNC(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)[Si](C)(C)C(C)(C)C)C=C2)=CC=N1 | 4653.8 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TBDMS,isomer #1 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]3O)C=C2)=CC=N1 | 4970.9 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TBDMS,isomer #10 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]3O[Si](C)(C)C(C)(C)C)C=C2)=CC=N1 | 4965.3 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TBDMS,isomer #11 | CN(C(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O[Si](C)(C)C(C)(C)C)C=C2)=CC=N1)[Si](C)(C)C(C)(C)C | 5035.6 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TBDMS,isomer #12 | CNC(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)=CC=N1 | 4771.6 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TBDMS,isomer #13 | CN(C(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]3O)C=C2)=CC=N1)[Si](C)(C)C(C)(C)C | 5047.4 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TBDMS,isomer #14 | CNC(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]3O)[Si](C)(C)C(C)(C)C)C=C2)=CC=N1 | 4780.5 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TBDMS,isomer #15 | CN(C(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)[Si](C)(C)C(C)(C)C)C=C2)=CC=N1)[Si](C)(C)C(C)(C)C | 4852.3 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TBDMS,isomer #2 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]3O)C=C2)=CC=N1 | 4959.2 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TBDMS,isomer #3 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]3O[Si](C)(C)C(C)(C)C)C=C2)=CC=N1 | 4961.2 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TBDMS,isomer #4 | CN(C(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]3O)C=C2)=CC=N1)[Si](C)(C)C(C)(C)C | 5039.7 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TBDMS,isomer #5 | CNC(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]3O)[Si](C)(C)C(C)(C)C)C=C2)=CC=N1 | 4766.1 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TBDMS,isomer #6 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]3O)C=C2)=CC=N1 | 4957.1 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TBDMS,isomer #7 | CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]3O[Si](C)(C)C(C)(C)C)C=C2)=CC=N1 | 4944.4 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TBDMS,isomer #8 | CN(C(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]3O)C=C2)=CC=N1)[Si](C)(C)C(C)(C)C | 5026.1 | Semi standard non polar | 33892256 | Sorafenib beta-D-Glucuronide,2TBDMS,isomer #9 | CNC(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]3O)[Si](C)(C)C(C)(C)C)C=C2)=CC=N1 | 4762.1 | Semi standard non polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (Non-derivatized) - 70eV, Positive | splash10-000i-9322163000-54fb357763970483dd0d | 2017-09-20 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_1_5) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_1_6) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_2_6) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_2_7) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_2_8) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_2_9) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_2_10) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_2_11) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_2_12) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_2_13) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_2_14) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_2_15) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_3_1) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_3_2) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sorafenib beta-D-Glucuronide GC-MS (TMS_3_3) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sorafenib beta-D-Glucuronide 10V, Positive-QTOF | splash10-014i-0001904000-77afae7c5dd756d9a3f9 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sorafenib beta-D-Glucuronide 20V, Positive-QTOF | splash10-0lk9-1134900000-1bffc1070bb835e1fba3 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sorafenib beta-D-Glucuronide 40V, Positive-QTOF | splash10-0a4i-0133900000-71962cb0bba5f185f955 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sorafenib beta-D-Glucuronide 10V, Negative-QTOF | splash10-03dr-0151968000-0cc0bb024009b1d9b613 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sorafenib beta-D-Glucuronide 20V, Negative-QTOF | splash10-03di-0140950000-9e5b40a4b46a004f059c | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sorafenib beta-D-Glucuronide 40V, Negative-QTOF | splash10-0006-4792500000-a80511e6b557923dfacf | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sorafenib beta-D-Glucuronide 10V, Negative-QTOF | splash10-0kg9-0138139000-e1f389ba05fd6d003fba | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sorafenib beta-D-Glucuronide 20V, Negative-QTOF | splash10-0a4l-6110294000-e0f30f817ff676b5381f | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sorafenib beta-D-Glucuronide 40V, Negative-QTOF | splash10-0006-9713203000-71ac59636f4d397c3bae | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sorafenib beta-D-Glucuronide 10V, Positive-QTOF | splash10-00dl-0002109000-62f8e1c06fa311179cfa | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sorafenib beta-D-Glucuronide 20V, Positive-QTOF | splash10-014i-0000933000-35c30825c89c1f04e4af | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sorafenib beta-D-Glucuronide 40V, Positive-QTOF | splash10-069c-0321942000-844e398ad2337b1e0e04 | 2021-10-12 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Normal | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | Not Available |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 71752221 |
---|
PDB ID | Not Available |
---|
ChEBI ID | Not Available |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | Not Available |
---|